ABRAXANE PI PDF

We need some information from you before you start using the platform. This information will allow us to better understand how AdisInsight is being used. It does not require or replace the individual login accounts that many of you use to save searches and create email alerts. Protecting your personal information is important. That is why AdisInsight collects the minimum amount of information necessary to enable functionality, report usage, and contact you with information about AdisInsight.

Author:Grozilkree Faetaxe
Country:Iran
Language:English (Spanish)
Genre:Marketing
Published (Last):15 May 2016
Pages:256
PDF File Size:3.63 Mb
ePub File Size:15.26 Mb
ISBN:664-9-58962-968-7
Downloads:24914
Price:Free* [*Free Regsitration Required]
Uploader:Tokazahn



We need some information from you before you start using the platform. This information will allow us to better understand how AdisInsight is being used. It does not require or replace the individual login accounts that many of you use to save searches and create email alerts. Protecting your personal information is important. That is why AdisInsight collects the minimum amount of information necessary to enable functionality, report usage, and contact you with information about AdisInsight.

For further information on how we protect and process your personal information, please refer to our privacy policy. How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform. The number of times you access AdisInsight, the number of searches you performed, and the number of profiles you viewed will be provided to your organization both in aggregate with other users and individually by your email address.

If you opt-out your email will still be collected for registration purposes. Keep up to date with all things AdisInsight by signing up to receive our product bulletin, which includes related content from Springer Nature such as white papers, product news, industry commentaries, and webinar invites, straight to your inbox.

Unsubscription is always possible via email. Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely.

Contact us at AsktheExpert. AdisInsight springer. To gain full access to the content and functionality of the AdisInsight database try one of the following. If you are a subscriber to this content then contact us at AsktheExpert. Welcome to AdisInsight. Please enter your official email address Email Address Please enter your official email address. We notice that your permissions preference cookie is missing. Please enter your email address so we can determine if you need to complete a permission form or verify that you have already completed this form.

Receiving permission from our users is an important part of our compliance with international privacy regulations. Your email address will not be shared without your permission.

Please refer to our privacy policy for information on how we protect your personal information. Welcome to AdisInsight We need some information from you before you start using the platform. Terms of Service By accessing or using the AdisInsight platform you agree to the terms of use. I agree to the terms of use Please select terms of use How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform.

I agree to share my email address with the organization providing my access to AdisInsight I do not agree to share my email address with the organization providing my access to AdisInsight Please choose your email permissions. Get more from AdisInsight Keep up to date with all things AdisInsight by signing up to receive our product bulletin, which includes related content from Springer Nature such as white papers, product news, industry commentaries, and webinar invites, straight to your inbox.

I would like to receive the product bulletins by email I would not like to receive the product bulletins by email service emails will still be sent Please choose your permissions Mandatory field.

Albumin-bound paclitaxel - Celgene Corporation. Next Previous. Drug Profile. Buy Profile. Adis is an information provider. We do not sell or distribute actual drugs. Final gross price and currency may vary according to local VAT and billing address. Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.

A link to download a PDF version of the drug profile will be included in your email receipt. Anderson Cancer Center; Washington University School of Medicine Class Antineoplastics; Diterpenes; Paclitaxels; Skin disorder therapies; Small molecules; Taxanes Mechanism of Action Angiogenesis inhibitors; Mitosis inhibitors; Platelet-derived growth factor inhibitors; Proto-oncogene protein c-bcl-2 inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters Orphan Drug Status Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

Restricted Access If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Other Sites Springer. Adis International Ltd. Not logged in Unaffiliated Back to top.

INTERTEMPORAL MACROECONOMICS AZARIADIS PDF

Welcome to AdisInsight

No new drugs have been approved by the TGA for this disease since The primary endpoint of the study was overall survival. Secondary endpoints were progression-free survival and overall response rate determined by independent radiological review. Other endpoints included the safety and tolerability of this combination in patients with metastatic pancreatic cancer. Neuropathy improved to grade 1 or lower in a median of 29 days for the ABRAXANE plus gemcitabine arm and was not reached for the gemcitabine alone arm.

GODSPELL 2012 SCORE PDF

NANOPARTICLE ALBUMIN-BOUND PACLITAXEL

Skip to main content Press Enter. Sign in. Skip auxiliary navigation Press Enter. Back to ONS. Skip main navigation Press Enter. Toggle navigation.

SEBHAT GEBREGZIABHER BOOKS PDF

Press Release

Breast cancer greatly threatens the health of women all over the word despite of several effective drugs. Targeted therapy for breast cancer is limited to human epidermal growth factor receptor 2 HER2. Despite these advances, further novel targeted therapy with more improved anti-tumor efficacy for breast cancer is still urgently needed. There are varoius modalities of treatment based on the stages, histologies, and biomarkers. Early-stage breast cancers are usually treated with surgery, neoadjuvant chemotherapy, radiotherapy and endocrinotherapy, while therapies for recurrent or metastatic stage IV breast cancer with poor prognosis must be balanced in benefit of length and quality of life.

EJERCICIOS DE ESTILO DE RAYMOND QUENEAU PDF

ABRAXANE - Prescribing Information

.

Related Articles